OSE Immunotherapeutics (XPAR:OSE) Receivables Turnover : 1.43 (As of Dec. 2023)

OSE Immunotherapeutics Receivables Turnover Chart

OSE Immunotherapeutics Annual Data
	Trend	Dec14	Dec15	Dec16	Dec17	Dec18	Dec19	Dec20	Dec21	Dec22	Dec23
Receivables Turnover		Get a 7-Day Free Trial					17.30	11.44	28.50	31.15	3.22

OSE Immunotherapeutics Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Receivables Turnover	Get a 7-Day Free Trial															23.02	27.24	5.57	4.26	1.43

Competitive Comparison of OSE Immunotherapeutics's Receivables Turnover

For the Biotechnology subindustry, OSE Immunotherapeutics's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

OSE Immunotherapeutics's Receivables Turnover Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, OSE Immunotherapeutics's Receivables Turnover distribution charts can be found below:

* The bar in red indicates where OSE Immunotherapeutics's Receivables Turnover falls into.

OSE Immunotherapeutics Receivables Turnover Calculation

Receivables Turnover measures the number of times a company collects its average accounts receivable balance.

OSE Immunotherapeutics's Receivables Turnover for the fiscal year that ended in Dec. 2023 is calculated as

OSE Immunotherapeutics's Receivables Turnover for the quarter that ended in Dec. 2023 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

OSE Immunotherapeutics  (XPAR:OSE) Receivables Turnover Explanation

An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.

OSE Immunotherapeutics Receivables Turnover Related Terms

Thank you for viewing the detailed overview of OSE Immunotherapeutics's Receivables Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.

OSE Immunotherapeutics (XPAR:OSE) Business Description